Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [2]
- Chromatin Immunoprecipitation [1]
- Other assay [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MA5-14898 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- AKT1 Monoclonal Antibody (G.145.7)
- Antibody type
- Monoclonal
- Antigen
- Synthetic peptide
- Description
- It is not recommended to aliquot this antibody. This antibody is not cross-reactive with Akt2 or Akt3.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Isotype
- IgG
- Antibody clone number
- G.145.7
- Vial size
- 100 µL
- Concentration
- 35 µg/mL
- Storage
- -20°C
Submitted references Protective role of wogonin following traumatic brain injury by reducing oxidative stress and apoptosis via the PI3K/Nrf2/HO‑1 pathway.
Oral Pathobiont Activates Anti-Apoptotic Pathway, Promoting both Immune Suppression and Oncogenic Cell Proliferation.
Hsp90-targeted miRNA-liposomal formulation for systemic antitumor effect.
Feng Y, Ju Y, Yan Z, Ji M, Yang M, Wu Q, Wang L, Sun G
International journal of molecular medicine 2022 Apr;49(4)
International journal of molecular medicine 2022 Apr;49(4)
Oral Pathobiont Activates Anti-Apoptotic Pathway, Promoting both Immune Suppression and Oncogenic Cell Proliferation.
Arjunan P, Meghil MM, Pi W, Xu J, Lang L, El-Awady A, Sullivan W, Rajendran M, Rabelo MS, Wang T, Tawfik OK, Kunde-Ramamoorthy G, Singh N, Muthusamy T, Susin C, Teng Y, Arce RM, Cutler CW
Scientific reports 2018 Nov 9;8(1):16607
Scientific reports 2018 Nov 9;8(1):16607
Hsp90-targeted miRNA-liposomal formulation for systemic antitumor effect.
Pore SK, Choudhary A, Rathore B, Ganguly A, Sujitha P, Kumar CG, Agawane SB, Kumar JM, Scaria V, Pillai B, Banerjee R
Biomaterials 2013 Sep;34(28):6804-17
Biomaterials 2013 Sep;34(28):6804-17
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of Akt1 in extracts from Akt3 (lane 1) knock-out mouse embryonic fibroblasts (MEFs) and matched wild-type MEFs (lane 2) using Akt1 monoclonal antibody (Product # MA5-14898) (upper) or an Akt2 antibody (lower).
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of Akt1 in recombinant Akt1, Akt2 and Akt3 proteins using Akt1 monoclonal antibody (Product # MA5-14898) (upper) or an Akt (pan) monoclonal antibody (lower).
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Chromatin immunoprecipitation analysis of Akt1 was performed using cross-linked chromatin from 1 x 106 HCT116 colon carcinoma cells treated with serum for 0, 15, 30, and 60 minutes. Immunoprecipitation was performed using a multiplex microplate Matrix ChIP assay (see reference for Matrix ChIP protocol: http://www.ncbi.nlm.nih.gov/pubmed/22098709) with 1.0 µL/100 µL well volume of an Atk1 monoclonal antibody (Product # MA5-14898). Chromatin aliquots from ~1 x 105 cells were used per ChIP pull-down. Quantitative PCR data were done in quadruplicate using 1 µL of eluted DNA in 2 µL SYBR real-time PCR reactions containing primers to amplify -15kb upstream of the Egr1 gene or exon-1 of Egr1. PCR calibration curves were generated for each primer pair from a dilution series of sheared total genomic DNA. Quantitation of immunoprecipitated chromatin is presented as signal relative to the total amount of input chromatin. Results represent the mean +/- SEM for three experiments. A schematic representation of the Egr-1 locus is shown above the data where boxes represent exons (black boxes = translated regions, white boxes = untranslated regions); the zigzag line represents an intron; and the straight line represents upstream sequence. Regions amplified by Egr-1 primers are represented by black bars. Data courtesy of the Innovators Program.
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Wogonin promotes the expression of p-Akt following TBI in the hippocampus through PI3K. (A) western blotting was performed on the levels of p-Akt and Akt in the hippocampal CA1 region of the sham group, TBI group, wogonin administration group (TBI + Wog), wogonin and LY294002 administration group (TBI + Wog + LY) and DMSO control group (TBI + DMSO) at 24 h after the operation. (B) The relative optical density of the p-Akt band was analyzed. (C) Representative immunofluorescence confocal images were shown to evaluate the colocalization of p-Akt (green) and NeuN (red). (D) The quantitative analysis of p-Akt-positive NeuN in the hippocampus. Scale bar, 50 u m. * P